Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Ondřej Fiala, Sebastiano Buti, Hideki Takeshita, Y. Okada, Francesco Massari, Geòrgia Anguera, Michele Dionese, Sarah Scagliarini, Thomas Büttner, Giuseppe Fornarini, Zin Myint, Luca Galli, Vinícius Carrera Souza, Renate Pichler, Ugo De Giorgi, María Natalia Gandur Quiroga, Danielle Gilbert, Lazar Popović, Enrique Grande, Giulia Mammone, Rossana Berardi, Simon J. Crabb, Javier Molina‐Cerrillo, Marcelo Freitas, Murilo Luz, Roberto Iacovelli, Fabio Calabrò, Deniz Tural, Francesco Atzori, Zsófia Kürönya, Rita Chiari, Saúl Campos-Gómez, Orazio Caffo, André P. Fay, Jakub Kucharz, Paolo Andrea Zucali, José Augusto Rinck, Annalisa Zeppellini, Diogo Assed Bastos, Gaetano Aurilio, Augusto Mota, Karine Martins da Trindade, Cinzia Ortega, Juan Pablo Sade, Mimma Rizzo, Nuno Vau, Patrizia Giannatempo, Allan Barillas, Fernando Sabino Marques Monteiro, Breno Dauster, Carlo Cattrini, Lucas Nogueira, Roni de Carvalho Fernandes, Emmanuel Seront, Luis García Aceituno, Francesco Grillone, Hernan Javier Cutuli, Mauricio Fernández, Maria Bassanelli, Giandomenico Roviello, Halima Abahssain, Giuseppe Procopio, Michèle Milella, Jindřich Kopecký, Angelo Martignetti, Carlo Messina, Manuel Caitano, Eva Inman, Ravindran Kanesvaran, Daniel Herchenhorn, Daniele Santini, Ray Manneh Kopp, Renato Bisonni, Roubini Zakopoulou, Alessandra Mosca, Franco Morelli, Fernando Cotait Maluf, Andrey Soares, Fernando Furlan Nunes, Álvaro Pinto, Anca Zgură, Lorena Incorvaia, Jawaher Ansari, Ignacio Ortego Zabalza, Johannes Landmesser, Alessandro Rizzo, Veronica Mollica, Giulia Sorgentoni, Nicola Battelli, Camillo Porta, Joaquim Bellmunt, Matteo Santoni